| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.3 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.3 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |